---
layout: single
title:  "US FDA grants accelerated approval for skin cancer cell therapy"
categories: oncology

---
Using a tumor derived immunotherapy composed of a patient's own disease-fighting white blood cells known as T-cells, with a specific type called tumor-infiltrating lymphocytes (TIL).

[Reuters](https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-grants-accelerated-approval-iovances-skin-cancer-cell-therapy-2024-02-16/)
